Urinary excretion of liver fatty acid-binding protein in health-check participants

Clinical and Experimental Nephrology

Volumn 9, Issue 1, 2005, Pages 34-39

  Ishimitsu, Toshihiko ^a   Ohta, Satoshi ^a   Saito, Mayumi ^a   Teranishi, Megumi ^a   Inada, Hideki ^a   Yoshii, Masayoshi ^a   Minami, Junichi ^a   Ono, Hidehiko ^a   Hikawa, Akihisa ^b   Shibata, Norio ^b   Sugaya, Takeshi ^c   Kamijo, Atsuko ^d   Kimura, Kenjiro ^d   Ohrui, Masami ^a   Matsuoka, Hiroaki ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b EIKEN CHEMICAL CO LTD   (Japan)

^c Strategic and Regulatory Affairs Consulting Department   (Japan)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aging; C reactive protein; Fatty acid binding protein; Renal injury

Indexed keywords

C REACTIVE PROTEIN; CREATININE; FATTY ACID BINDING PROTEIN; GLUCOSE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HUMAN; HYPERTENSION; KIDNEY INJURY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PROTEIN DETERMINATION; PROTEIN URINE LEVEL; REGRESSION ANALYSIS; SEX RATIO; URINALYSIS; URINARY EXCRETION;

ADULT; AGED; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CARRIER PROTEINS; CHRONIC DISEASE; CREATININE; DIABETES MELLITUS; FASTING; FATTY ACID-BINDING PROTEINS; FEMALE; HEPATITIS; HOSPITALIZATION; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; REGRESSION ANALYSIS; SEX FACTORS;

EID: 20244380486     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-004-0331-x     Document Type: Article

References (26)

1. Arici M, Ghana R, Lewington A, Brown J, Brunskill NJ. Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptorgamma. J Am Soc Nephrol 2003;14:17-27.
2. Thomas ME, Schreiner GF. Contribution of proteinuria to progressive renal injury: consequences of tubular uptake of fatty acid bearing albumin. Am J Nephrol 1993;13:385-98.
3. Thomas ME, Morrison AR, Schreiner GF. Metabolic effects of fatty acid-bearing albumin on a proximal tubule cell line. Am J Physiol 1995;268:F1177-84.
4. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hase H, Kaneko T, et al. Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int 2002;2:1628-37.
5. Veerkamp JH, Peelers RA, Maatman RG. Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochim Biophys Acta 1991;1081:1-24.
6. Schroeder F, Jolly CA, Cho TH, Frolov A. Fatty acid binding protein isoforms: structure and function. Chem Phys Lipids 1998;92:1-25.
7. Wolfrum C, Borrmann CM, Borchers T, Spener F. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha- and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc Natl Acad Sci U S A 2001;98:2323-8.
8. Mandard S, Muller M, Kersten S. Peroxisome proliferatoractivated receptor alpha target genes. Cell Mol Life Sci 2004;61:393-416.
9. Corton JC, Anderson SP, Stauber A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol 2000;40:491-518.
10. Maatman RG, van de Westerlo EM, van Kuppeveit TH, Veerkamp JH. Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochem J 1992;288:285-90.
11. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hikawa A, Hirano N, et al. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med 2004;143:23-30.
12. Saito M, Ishimitsu T, Minami J, Ono H, Ohrui M, Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 2003;167:73-9.
13. Izzo C, Grillo F, Murador E. Improved method for determination of high-density-lipoprotein cholesterol I. Isolation of high-density lipoproteins by use of polyethylene glycol 6000. Clin Chem 1981;27:371-4.
14. Parving HH, Mogensen CE, Jensen HA, Evrin PE. Increased urinary albumin-excretion rate in benign essential hypertension. Lancet 1974;1:1190-2.
15. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984;310:356-60.
16. Redon J, Gomez-Sanchez MA, Baldo E, Casal MC, Fernandez ML, Miralles A, et al. Micro-albuminuria is correlated with left ventricular hypertrophy in male hypertensive patients. J Hypertens Suppl 1991;9:S148-9.
17. Pedrinelli R, Lindpaintner K, Dell'Omo G, Napoli V, Di Bello V, De Caterina R, et al. Urinary albumin excretion and atherosclerosis in essential hypertension. Clin Sci 1997;92:45-50.
18. Saluja I, Song D, O'Regan MH, Phillis JW. Role of phospholipase A2 in the release of free fatty acids during ischemia-reperfusion in the rat cerebral cortex. Neurosci Lett 1997;233:97-100.
19. Walker PD, Shah SV. Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats. J Clin Invest 1988;81:334-41.
20. Meunier-Durmort C, Poirier H, Niot I, Forest C, Besnard P. Up-regulation of the expression of the gene for liver fatty acid-binding protein by long-chain fatty acids. Biochem J 1996;319:483-7.
21. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
22. Ridker PM, Cushman M, Stampfer MJ, Tracy R, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
23. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
24. Nagahama K, Iseki K, Inoue T, Tourna T, Ikemiya Y, Takishita S. Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res 2004;27:227-33.
25. Yeum KJ, Russell RM, Krinsky NI, Aldini G. Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma. Arch Biochem Biophys 2004;430:97-103.
26. Kamijo A, Kimura K, Sugaya T, Hikawa A, Yamanouti M, Hirata Y, et al. Urinary excretion of liver type fatty acid binding protein (L-FABP) is a new clinical marker for prognosis of chronic glomerular disease. (abstract). J Am Soc Nephrol 2001;12(suppl):74A.